ASENSUS SURGICAL, INC. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Revenue
Product
Service
Lease
Total revenue
Cost of revenue:
Product
Service
Lease
Total cost of revenue
Gross loss
Operating Expenses:
Research and development
Sales and marketing
General and administrative
Amortization of intangible assets
Change in fair value of contingent consideration
Restructuring and other charges
Goodwill impairment
Intangible assets impairment
Acquisition related costs
Loss (gain) from sale of assets, net
SurgiBot System
AutoLap
Reversal of transfer fee accrual
Gain (loss) from sale of assets, net
SurgiBot System
Auto Lap
Impairment of property and equipment
Total operating expenses
Operating loss

Other Income (Expense), net
Gain on extinguishment of debt
Change in fair value of warrant liabilities
Interest income
Interest expense
Employee retention tax credit
Other expense, net
Total other income (expense), net
Loss before income taxes
Income tax expense
Net loss
Deemed dividend related to beneficial conversion feature of preferred stock
Deemed dividend related to conversion of preferred stock into common stock
Net loss attributable to common stockholders
Foreign currency translation gain (loss)
Unrealized gain (loss) on available-for-sale investments
Comprehensive loss
Net loss per common share attributable to common stockholders - basic and diluted (in dollars per share)
Weighted average number of shares used in computing net loss per common share - basic and diluted (in shares)

Comments